Amedeo Smart

Free Medical Literature Service


 

Amedeo

Drug Resistance

  Free Subscription

01.09.2025

1 Emerg Infect Dis
10 J Antimicrob Chemother
1 J Clin Microbiol
3 PLoS One



    Emerg Infect Dis

  1. DO PRADO CM, Spruijtenburg B, Razzolini E, Chiyo L, et al
    Sporothrix brasiliensis Treatment Failure without Initial Elevated Itraconazole MICs in Felids at Border of Brazil.
    Emerg Infect Dis. 2025;31:1783-1792.
    >> Share


    J Antimicrob Chemother

  2. LI J, Hou W, Chang J, Tian X, et al
    The pivotal role of acnA in linking carbon metabolism to virulence and antimicrobial resistance in methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 2025 Aug 28:dkaf317. doi: 10.1093.
    >> Share

  3. MCCRACKEN M, Walkty A, Adam HJ, Baxter M, et al
    Characterization of carbapenem-resistant Pseudomonas aeruginosa in Canadian hospitals: 6 years of the CANWARD study (2018-23).
    J Antimicrob Chemother. 2025;80.
    >> Share

  4. MATASEJE LF, Lerminiaux N, Lagace-Wiens P, Walkty A, et al
    Characterization of ertapenem-resistant Enterobacterales in Canadian hospitals: 17 years of the CANWARD study (2007-23).
    J Antimicrob Chemother. 2025;80.
    >> Share

  5. ADAM HJ, Golden AR, Martin I, Baxter MR, et al
    Comparison of antimicrobial resistance and serotype patterns in Streptococcus pneumoniae from blood cultures and respiratory specimens in Canadian hospitals from the CANWARD study (2007-23).
    J Antimicrob Chemother. 2025;80.
    >> Share

  6. BRAHAMI A, Karlowsky JA, McCracken M, Golding GR, et al
    Characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 17 years of the CANWARD study (2007-23).
    J Antimicrob Chemother. 2025;80.
    >> Share

  7. ZHANEL GG, Baxter MR, Lagace-Wiens P, Walkty A, et al
    Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).
    J Antimicrob Chemother. 2025;80.
    >> Share

  8. ZHANEL GG, Baxter MR, Golden AR, Lagace-Wiens P, et al
    Gram-positive pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).
    J Antimicrob Chemother. 2025;80.
    >> Share

  9. LAGACE-WIENS P, Mataseje L, McCracken M, Walkty A, et al
    Increasing rates of ESBL-producing Escherichia coli and Klebsiella pneumoniae in Canadian Hospitals: 17 years of the CANWARD study, 2007-23.
    J Antimicrob Chemother. 2025;80.
    >> Share

  10. HAO J, Lu F, Chen P, Ji C, et al
    Characterization of blaOXA-542-mediated carbapenem resistance in Acinetobacter baumannii.
    J Antimicrob Chemother. 2025 Aug 29:dkaf311. doi: 10.1093.
    >> Share

  11. HURLEY JC, Madec JY
    The CANWARD studies: Canadian Antimicrobial Resistance Alliance (CARA) Canadian Hospital Ward Antibiotic Resistance Surveillance collection.
    J Antimicrob Chemother. 2025;80.
    >> Share


    J Clin Microbiol

  12. CALDERA JR, Dayo A, Wiederhold N, Yang S, et al
    Development and validation of next-generation sequencing-based clinical test for triazole resistance prediction in Aspergillus fumigatus.
    J Clin Microbiol. 2025 Jul 1:e0029125. doi: 10.1128/jcm.00291.
    >> Share


    PLoS One

  13. GONG P, Zhou Y, Gao D, Wan P, et al
    Impacts of cellulase and xylanase addition on antibiotic resistance and microbial community during dairy manure composting.
    PLoS One. 2025;20:e0328055.
    >> Share

  14. AL-OUQAILI MTS, Hussein RA, Kanaan BA, Al-Neda ATS, et al
    Investigation of carbapenemase-encoding genes in Burkholderia cepacia and Aeromonas sobria isolates from nosocomial infections in Iraqi patients.
    PLoS One. 2025;20:e0315490.
    >> Share

  15. JEON W, Lee YM, Kim DY, Park KH, et al
    Visualization of multidrug-resistant bacterial infection trends in the intensive care units.
    PLoS One. 2025;20:e0330765.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016